Today's Date
Carfilzomib and Belatacept for Desensitization
(
ADAPT
)
ITN Protocol #:
ITN089ST
Branded Name:
ADAPT
ClinicalTrials.Gov ID:
NCT05017545Treatment Protocol #:
Therapeutic Area:
Transplantation
Current Status:
Enrollment
Summary:
Measuring the Impact of Carfilzomib and Belatacept on Allogeneic Desensitization in Prospective Kidney Transplant Recipients
Clinical Operations Manager
ITN Biologist
ITN Clinical Trial Physician
Rho Scientist
Study Personnel:
